A carregar...
Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects
Recent advances in the management of prostate cancer have shown considerable development with time and many novel therapeutic agents have been approved over the past years. For patients with metastatic castration-resistant prostate cancer (mCRPC), initially docetaxel was the standard chemotherapy bu...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3825997/ https://ncbi.nlm.nih.gov/pubmed/24250198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.119704 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|